You are here: Industry Insights > University of Sheffield

News List

Parkinson's UK Implements CDD Vault to Manage Its Pioneering Drug Discovery Data prnasia
July 19, 2021
Parkinson's UK, the largest charitable funder of Parkinson's research in Europe, has announced today that it is using Collaborative Drug Discovery's CDD Vault informatics system to manage project data from the Parkinson's Virtual Biotech ...
Osteoporosis drug may halve repeat hip replacement procedures: Study expresspharma
January 15, 2021
Researchers from the University of Sheffield and Sheffield Teaching Hospitals found the osteoporosis drug, denosumab, could protect patients from osteolysis, reduce the need for re-operations, and reduce the health burden of this disease.
Sheffield University gets £3.1 mn for trials to better bladder, prostate cancer diagnosis, treatment expresspharma
November 19, 2020
The two trials are part of a wider £8.3 million funding boost for new research programmes across Yorkshire.
Scientists at University of Sheffield discover new drug to treat pancreatic cancer expresspharma
September 18, 2020
Scientists at the University of Sheffield inform that they have invented a new drug which could improve life expectancy and quality for patients with hard-to-treat cancers, such as pancreatic cancer and relapsed breast cancer.
New research into stem cell mutations could improve regenerative medicine expresspharma
May 19, 2020
The new research has suggested ways to reduce the likelihood of mutations occurring in these cells when cultured.
Liver disease drug could help restore cells damaged by Alzheimer’s financialexpress
September 07, 2018
New study found ursodeoxycholic acid (UDCA) improves mitochondrial dysfunction – which is known to be a causative factor for both sporadic and familial Alzheimer’s disease
University of Sheffield and Parkinson’s UK launch new virtual biotech company pharmaceutical-technology
March 10, 2017
The University of Sheffield and research and support charity Parkinson’s UK have launched a new virtual biotech company to develop new treatments for people with Parkinson’s.